Changes of plasma fibronectin in patients treated with cryofiltration for an extended period

Therapeutic Apheresis

Volumn 3, Issue 4, 1999, Pages 338-341

  Yonekawa, Motoki ^a   Kawamura, Akio ^a   Kukita, Kazutaka ^a   Meguro, Jun Ichi ^a   Tanaka, Mitsuko ^a   Tamaki, Tohru ^a  

^a SAPPORO HOKUYU HOSPITAL   (Japan)

Author keywords

Cellular fibronectin; Cryofiltration; Extra domain A fibronectin; Fibronectin

Indexed keywords

FIBRONECTIN;

ADULT; ANKYLOSING SPONDYLITIS; AORTITIS; AUTOIMMUNE DISEASE; BLOOD FILTRATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CRYOFILTRATION; CRYOTHERAPY; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY GRAFT REJECTION; MALE; PLASMAPHERESIS; POLYMYOSITIS; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANALYSIS OF VARIANCE; AORTITIS; ARTHRITIS, JUVENILE RHEUMATOID; AUTOIMMUNE DISEASES; CHILD; FEMALE; FIBRONECTINS; FOLLOW-UP STUDIES; GRAFT REJECTION; HEMODIAFILTRATION; HUMANS; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PLASMAPHERESIS; POLYMYOSITIS; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME;

EID: 0032728441     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.1999.00206.x     Document Type: Conference Paper

References (13)

1. Yonekawa M, Kamii N, Onodera K, Takahashi M, Witmanouski H, Kukita K, Meguro J, Kawamura A, Naohara T, Higa T, Kasai M. Cryofiltration for rheumatoid arthritis. In: Yamagata J, Inoue N, Nakagawa S, eds. Ther plasmapheresis (X). Cleveland: ICAOT Press, 1992:7-11.
2. Tamaki T, Tanaka M, Katori M, Osanai M, Yasuhara M, Meguro J, Kukita K, Yonekawa M, Kawamura A. Cryofiltration apheresis for major ABO-incompatible kidney transplantation. Ther Apheresis 1998;2:308-10.
3. Kawamura A, Osanai M, Yonekawa M. Immunomodulation in transplant patients by cryofiltration. Ther Apheresis 1998; 2:205-9.
4. Yonekawa M, Kon H, Takahashi M, Onodera K, Meguro J, Kukita K, Kawamura A, Komai T, Matsuda M, Sekiguchi K, Hirano H, Sakashita E. Changes of EDA(+)fibronectin in plasma in patients with immune complex diseases and its reduction on cryofiltration. Jpn J Artif Organs 1993;22:220-5.
5. Umemoto R, Asakura S, Kariya Y, Yonekawa M, Kawamura A, Komai T, Sekiguchi K, Hirano H, Hino K, Sakashita E, Matsuda M. Cellular fibronectin in plasma: Its implications in fibrinogen-associated cryoprecipitation and other related reactions. Blood Coag Fibrinolysis 1993;4:127-31.
6. Sakashita E, Kobayashi N, Miyashita K, Hino K, Umemoto R, Yonekawa M, Kawamura A, Hirano H, Sekiguchi K, Komai T, Matsuda M. The role of EDA(+)fibronectin in the specific removal of compounds through cryofiltration. Jpn J Artif Organs 1994;23:511-7.
7. Kawamura A, Yonekawa M, Takahashi M, Meguro J, Yanagida N, Kurauchi N, Ikeda A, Kukita K, Sakashita E. Reduction of EDA(+)fibronectin and its clinical importance on cryofiltration. Int J Artif Organs 1994;17:559-64.
8. Takahashi M, Yonekawa M, Meguro J, Kukita K, Kawamura A, Yanagida N, Okano M, Kurauchi N, Imai M, Ohnishi K, Sugioka Y, Sakashita E. Development of an automatic cryofiltration system. Jpn J Apheresis 1996;15:122-3.
9. Hirano H, Tachikawa T, Hino K, Sakashita E, Sekiguchi K. Development of enzyme-linked immunosorbent assay (ELISA) for the detection of cellular type fibronectin by EDA-region specific monoclonal antibody. J Clin Lab Instrum Reag 1992;15:179-84.
10. Peters JH, Maunder RJ, Woolf AD, Cochrane CG, Ginsberg MH. Elevated plasma levels of EDA+["cellular"] fibronectin in patients with vascular injury. J Lab Clin Med 1989;113: 586-97.
11. Yonekawa M, Takahashi M, Kukita K, Meguro J, Tamaki T, Kawamura A, Yanagida N, Kurauchi N, Okano M, Imai M, Sakashita E. Influences of extracorporeal circulation and anticoagulants on elevation of EDA(+)fibronectin in plasma. Jpn J Artif Organs 1995;24:770-4.
12. Yonekawa M, Kukita K, Meguro J, Kawamura A, Yanagida N, Kurauchi N, Takahashi M, Ikeda A, Sakashita E, Kume Y. Clearance and reduction efficiency on cryofiltration. Jpn J Artif Organs 1994;23:1003-7.
13. Hino K, Shiozawa S, Kuroki Y, Ichikawa H, Shiozawa K, Sekiguchi K, Hirano H, Sakashita E, Miyashita K, Chihara K. EDA containing fibronectin is synthesized from rheumatoid synovial fibroblast-like cells. Arthritis Rheum 1995;38:678-83.